OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anticipated pharmacological role of Aviptadil on COVID-19
Tuhin Mukherjee, Tapan Behl, Sanchay Sharma, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 6, pp. 8109-8125
Open Access | Times Cited: 13
Tuhin Mukherjee, Tapan Behl, Sanchay Sharma, et al.
Environmental Science and Pollution Research (2021) Vol. 29, Iss. 6, pp. 8109-8125
Open Access | Times Cited: 13
Showing 13 citing articles:
Renewable and non-renewable electricity consumption, economic growth and climate change: Evidence from a panel of selected African countries
Riadh Brini
Energy (2021) Vol. 223, pp. 120064-120064
Closed Access | Times Cited: 86
Riadh Brini
Energy (2021) Vol. 223, pp. 120064-120064
Closed Access | Times Cited: 86
A Novel Regulator of NLRP3 Inflammasome: Peptides
Zhuo Zuo, Ya Xing Wang, Yanwei Fang, et al.
Peptides (2025) Vol. 187, pp. 171381-171381
Closed Access
Zhuo Zuo, Ya Xing Wang, Yanwei Fang, et al.
Peptides (2025) Vol. 187, pp. 171381-171381
Closed Access
Exosomes in COVID‐19 infection: Focus on role in diagnosis, pathogenesis, immunity, and clinical trials
Alhanouf Aljuhani, Omniah Albalawi, Rahaf Albalawi, et al.
Cell Biology International (2023) Vol. 47, Iss. 6, pp. 1049-1067
Closed Access | Times Cited: 9
Alhanouf Aljuhani, Omniah Albalawi, Rahaf Albalawi, et al.
Cell Biology International (2023) Vol. 47, Iss. 6, pp. 1049-1067
Closed Access | Times Cited: 9
Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables
Pablo Delgado‐Wicke, Sara Fernández de Córdoba‐Oñate, Emilia Roy‐Vallejo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Pablo Delgado‐Wicke, Sara Fernández de Córdoba‐Oñate, Emilia Roy‐Vallejo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Phytochemicals of Withania somnifera as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery
Suaidah Ramli, Yuan Seng Wu, Kalaivani Batumalaie, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 1000-1000
Open Access | Times Cited: 8
Suaidah Ramli, Yuan Seng Wu, Kalaivani Batumalaie, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 1000-1000
Open Access | Times Cited: 8
Reshaping of Italian Echocardiographic Laboratories Activities during the Second Wave of COVID-19 Pandemic and Expectations for the Post-Pandemic Era
Quirino Ciampi, Francesco Antonini‐Canterin, Andréa Barbieri, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3466-3466
Open Access | Times Cited: 18
Quirino Ciampi, Francesco Antonini‐Canterin, Andréa Barbieri, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3466-3466
Open Access | Times Cited: 18
Bioinformatics and systems biology analysis revealed PMID26394986-Compound-10 as potential repurposable drug against covid-19
Haseeb Nisar, Bilal Wajid, Faria Anwar, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 15, pp. 7972-7985
Open Access | Times Cited: 5
Haseeb Nisar, Bilal Wajid, Faria Anwar, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 15, pp. 7972-7985
Open Access | Times Cited: 5
The role of vasoactive intestinal peptide in pulmonary diseases
Hong-Lin Zhong, P. Li, Diyan Li, et al.
Life Sciences (2023) Vol. 332, pp. 122121-122121
Closed Access | Times Cited: 4
Hong-Lin Zhong, P. Li, Diyan Li, et al.
Life Sciences (2023) Vol. 332, pp. 122121-122121
Closed Access | Times Cited: 4
Greener Cleavage of Protected Peptide Fragments from Sieber Amide Resin
Othman Al Musaimi, Varshitha Gavva, Daryl R. Williams
ChemistryOpen (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 4
Othman Al Musaimi, Varshitha Gavva, Daryl R. Williams
ChemistryOpen (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 4
Therapeutic Polypeptides and Peptidomimetics: Powerful Tools for COVID-19 Treatment
Xinyu Liu, Jian Shi, Deyang Wang, et al.
Clinical Drug Investigation (2022) Vol. 43, Iss. 1, pp. 13-22
Open Access | Times Cited: 3
Xinyu Liu, Jian Shi, Deyang Wang, et al.
Clinical Drug Investigation (2022) Vol. 43, Iss. 1, pp. 13-22
Open Access | Times Cited: 3
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial
Maria Boesing, Kristin Abig, Michael Brändle, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Maria Boesing, Kristin Abig, Michael Brändle, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Aviptadil: A promising treatment option for acute respiratory distress syndrome
Agam Vora, Parthiv Mehta, V.K. Arora, et al.
Indian Journal of Tuberculosis (2023) Vol. 70, Iss. 4, pp. 510-511
Open Access
Agam Vora, Parthiv Mehta, V.K. Arora, et al.
Indian Journal of Tuberculosis (2023) Vol. 70, Iss. 4, pp. 510-511
Open Access
Inhaled Aviptadil for the treatment of COVID-19 in patients at high risk for ARDS: Study protocol for a randomized, placebo controlled multicentre trial.
Maria Boesing, Kristin Abig, Michael Brändle, et al.
Research Square (Research Square) (2022)
Open Access
Maria Boesing, Kristin Abig, Michael Brändle, et al.
Research Square (Research Square) (2022)
Open Access
